ONCOS THERAPEUTICS
Oncos Therapeutics develops new cancer therapies based on its next generation oncolytic viruses. The company's unique Advanced Therapy Access Program was started in 2007 for cancer patients in whom standard-of-care therapies have failed. Today, 200 patients have undergone individually tailored oncolytic virus therapy suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for ongoing clinical development.
ONCOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.oncos.com
Total Employee:
11+
Status:
Active
Contact:
358 4005 69628
Email Addresses:
[email protected]
Total Funding:
5.5 M USD
Technology used in webpage:
Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online IPv6 ReCAPTCHA Microsoft Azure DNS BootstrapCDN ASP.NET IIS
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
HealthCap
HealthCap investment in Series C - Oncos Therapeutics
Official Site Inspections
http://www.oncos.com
- Host name: res3009pi.cloudpanel.it
- IP address: 185.201.65.96
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
